Stemtech Corporation
STEK
Rank in Stocks
#33743
Stemtech Corporation is a pioneering company specializing in stem cell... Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$207.74K
Change (1 day)
0.00%
Change (1 year)
-95.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Stemtech Corporation (STEK)
Category
Healthcare
EPS for Stemtech Corporation (STEK)
EPS as of September 2026 TTM: $-0.01
According to Stemtech Corporation's latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.02, an increase over its 2024 EPS of $-0.03.
EPS history for Stemtech Corporation from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -57.50% |
| 2025 | $-0.02 | -25.16% |
| 2024 | $-0.03 | -51.15% |
| 2023 | $-0.07 | -65.74% |
| 2022 | $-0.19 | -53.66% |
| 2021 | $-0.41 | -87.19% |
| 2020 | $-3.20 | 515.38% |
| 2019 | $-0.52 | 653.62% |
| 2018 | $-0.07 | -19.58% |
| 2017 | $-0.09 | 63.12% |
| 2016 | $-0.05 | 43.32% |
| 2015 | $-0.04 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | -71,040.00% |
DE
|
|
| $6.01 | -70,780.00% |
DE
|
|
| $1.53 | -18,134.12% |
JP
|
|
| $3.66 | -43,158.82% |
CH
|
|
| $0.45 | -5,394.12% |
IL
|
Questions about Stemtech Corporation's earnings per share (EPS)
What is Stemtech Corporation's earnings per share (EPS)?
Stemtech Corporation's earnings per share (EPS) over the last twelve months is $-0.01, as of Sep 2026.
What was Stemtech Corporation's earnings per share (EPS) in 2025?
In 2025, Stemtech Corporation's earnings per share (EPS) was $-0.02, compared with $-0.03 in 2024.
How has Stemtech Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Stemtech Corporation's earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2020 ($-3.20).
How does Stemtech Corporation's earnings per share (EPS) compare with similar companies?
Stemtech Corporation's earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.